Vaxem Hib

Vaxem Hib: Protect Your Child from Haemophilus Influenzae Type b

Vaxem Hib is a vaccine designed to prevent invasive diseases caused by Haemophilus influenzae type b (Hib). This vaccine is crucial for children aged 6 weeks through 4 years, as it helps build immunity against Hib bacteria, which can lead to serious infections like meningitis and pneumonia.

How It Works

The Vaxem Hib vaccine is a polysaccharide conjugate vaccine, meaning it combines a piece of the Hib bacterium’s polysaccharide capsule with a protein carrier. This conjugation process enhances the vaccine’s effectiveness by making it more recognizable to the immune system.

Why It’s Important

Haemophilus influenzae type b is a significant threat to young children, particularly those under the age of 5. The vaccine is highly effective, with over 95% of infants developing protective antibody levels after completing the primary series. This means that with Vaxem Hib, you can significantly reduce the risk of your child contracting invasive Hib disease.

Safety and Efficacy

Vaxem Hib has been thoroughly tested and approved by regulatory authorities. It is safe for use in children and has been shown to provide long-lasting immunity. While the exact duration of immunity is not known, the vaccine is highly effective in producing protective antibodies.

Additional Information

• Manufacturer: GlaxoSmithKline Biologicals.
• Indication: Active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b.
• Age Range: 6 weeks through 4 years (prior to fifth birthday).

By choosing Vaxem Hib, you are providing your child with a critical layer of protection against a potentially life-threatening infection. Ensure your child’s safety and health with this reliable and effective vaccine.